Amid the shortage of anti-viral drug Remdesivir in the country in wake of devastating COVID-19 situation, AIIMS (All India Institute of Medical Sciences) Director Randeep Guleria said Remdesivir is not a "magic bullet", and the anti-viral drug is given to only those patients who are hospitalised.
"Remdesivir not a magic bullet, it's given to only patients who are hospitalised, have moderate to severe disease and whose oxygen saturation is below 93...Don't misuse Oxygen and Remdesivir.
Most patients can recover by isolating at home," Guleria said during conference with three other India's top doctors who addressed issues related to COVID-19 situation.
Sitaram Yechury, the 72-year-old General Secretary of CPM, passed away at AIIMS Delhi due to lung complications. Born in 1952, Yechury rose from student activism to lead the CPM, becoming its General Secretary in 2015. A native of Andhra Pradesh, he was educated at St. Stephen's College and JNU. Yechury's political journey included key roles in SFI and CPM.
#SitaramYechury #CPM #Yechury #AIIMS #SitaramYechuryNews #RIPYechury #SIF #Worldnews #Oneindia #Oneindianews
~HT.178~PR.320~ED.101~GR.124~
A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccineโs potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research.
#IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity
~HT.97~PR.152~
Amid rising concerns about shortage of medicines and oxygen while the country reels under a massive... IndiaTimes - Published Also reported by •Zee News
AIIMS Director Dr. Randeep Guleria explained when a person can end home isolation. Dr. Guleria said it is important to understand whwn to end home isolation in mild or asymptomatic cases. The pandemic..
Credit: HT Digital Content Duration: 03:08Published
During a press conference in Delhi over COVID situation in India, AIIMS Delhi Director Dr Randeep Guleria on April 30 advised people on when to discontinue home isolation. "When to discontinue home..
Amid increasing demand for Remdesivir injections across the country in wake of the devastating second wave of COVID-19, Delhi AIIMS Director Dr Randeep Guleria on April 30 advised people not to take..